| Literature DB >> 35893919 |
Gavin Reynolds1,2, Simon Epps1,2, Alyson Huntley3, Denize Atan1,2.
Abstract
Idiopathic intracranial hypertension (IIH) is a neurological disorder characterised by optic disc swelling secondary to raised intracranial pressure (ICP) of unknown cause. Obesity is the most established and prevalent risk factor in developed countries. As obesogenic diets are high in calories and nutrient-poor, there may be associated nutritional deficiencies that contribute to the clinical presentation of IIH. Yet none, aside from iron deficiency, are currently included in the inclusion or exclusion criteria for the diagnosis of IIH. Our primary aim was to determine which micronutrient deficiencies, aside from iron deficiency, could present with optic disc swelling associated with or without intracranial hypertension that could potentially meet current IIH diagnostic criteria. To this end, we conducted a systematic search of articles published between 1 January 1980 and 18 December 2020 reporting cases of optic disc swelling associated with micronutrient deficiencies. In total, 65 cases met the eligibility criteria from initial searches: all were case reports and case series with a high risk of bias. Our findings suggest that patients with IIH or unexplained optic disc swelling ought to be screened, investigated, and treated for associated micronutrient deficiencies in vitamin A, B1 and B12; and weight loss interventions in IIH patients ought to promote better nutrition in addition to overall calorie restriction.Entities:
Keywords: disc swelling; idiopathic intracranial hypertension (IIH); nutritional deficiency; obesity; papilledema
Mesh:
Substances:
Year: 2022 PMID: 35893919 PMCID: PMC9331791 DOI: 10.3390/nu14153068
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 6.706
Established associations with IIH.
|
| |
|
|
Patient characteristics and causes of nutritional deficiencies.
| Vitamin A | Vitamin B1 | Vitamin B12 | Presumed | Whole series | |
|---|---|---|---|---|---|
|
| |||||
| (i) Sex | |||||
| Male (M) (n, %) | 9M (75%) | 4M (10.0%) | 9M (81.8%) | 0M (0%) | 22M (33.9%) |
| Female (F) (n, %) | 3F (25%) | 36F (90.0%) | 2F (18.2%) | 2F (100%) | 43F (66.1%) |
| Pregnant females (n, %) | 0/3F (0%) | 15/36F (41.7%) | 0/2F (0%) | 0/2F (0%) | 15/43 (34.8%) |
| (ii) Mean age (range) | 10.2 | 28.1 | 23.0 | 14.0 | 23.4 |
|
| |||||
| (i) Malabsorption (n, %) | 4/12 (33.3%) | 15/40 (37.5%) | 0/11 (0%) | 2/2 (100%) | 21/65 (32.3%) |
| Post-surgical (n, %) | 1/12 (8.3%) | 11/15 (73.3%) | 0 (0%) | 0/2 (0%) | 12/65 (18.5%) |
| Gastro-intestinal pathology (n, %) | 3/12 (25.0%) | 4/15 (26.7%) | 0 (0%) | 2/2 (100%) | 9/65 (13.8%) |
| (ii) Dietary (%) | 8/12 (66.6%) | 25/40 (62.5%) | 9/11 (81.8%) | 0/2 (0%) | 42/65 (64.6%) |
| Hyperemesis gravidarum (n, %) | 0/8 (0%) | 15/25 (60.0%) | 0/10 (0%) | 0 (0%) | 15/65 (23.1%) |
| Nausea and vomiting (n, %) | 0/8 (0%) | 5/25 (20.0%) | 0/10 (0%) | 0 (0%) | 5/65 (7.7%) |
| Reduced intake (n, %) | 8/8 (100%) | 5/25 (20.0%) | 9/9 (100%) | 0 (0%) | 22/65 (33.8%) |
| (iii) Undetermined (%) | 0/12 (0%) | 0/12 (0.0%) | 2/11 (18.2%) | 0 (0%) | 2/65 (3.0%) |
Figure 1Clinical symptoms and signs of patients presenting with bilateral optic disc swelling associated with deficiencies in (A) vitamin A, (B) thiamine, and (C) vitamin B12.
Clinical and investigation results compared against IIH diagnostic criteria.
| IIH Diagnostic Criteria | Vitamin A | Vitamin B1 | Vitamin B12 | Presumed | Whole Series |
|---|---|---|---|---|---|
| (i) Papilledema (n, %) | 12/12 (100%) | 40/40 (100%) | 11/11 (100%) | 2/2 (100%) | 65/65 (100%) |
| (ii) Normal neurological examination * (n, %) | 11/12 (91.7%) | 3/40 (7.5%) | 11/11 (100%) | 2/2 (100%) | 30/65 (46.2%) |
| (iii) Reported Lumbar puncture results (n, %) | 10/12 (83.3%) | 11/40 (27.5%) | 04/11 (36.4%) | 2/2 (100%) | 25/65 (38.5%) |
| Raised opening pressure (n, %) | 7/10 (70.0%) | 0/11 (0%) | 3/4 (75.0%) | 2/2 (100%) | 12/27 (44.4%) |
| Normal opening pressure (n, %) | 3/10 (30.0%) | 11/11 (100%) | 1/4 (25.0%) | 0/0 (0%) | 15/27 (55.6%) |
| Normal CSF constituents (n, %) | 10/10 (100%) | 11/11 (100%) | 4/4 (100%) | 2/2(100%) | 25/25 (100%) |
| (iv) Reported neuro-imaging results (n, %) | 11/12 (91.7%) | 32/40 (80.0%) | 10/11 (90.9%) | 2/2 (100%) | 55/65 (84.8%) |
| No abnormality (n, %) | 9/11 (81.8%) | 7/32 (21.9%) | 8/10 (80.0%) | 2/2 (100%) | 26/55 (47.3%) |
| Other pathological features (n, %) | 2/11 (18.2%) | 25/32 (78.1%) | 2/10 (20.0%) | 0/2 (0%) | 29/55 (52.7.2%) |
| Cases meeting IIH diagnostic criteria of definite or probable IIH (n, %) | 11/12 (91.7%) | 3/40 (7.5%) | 11/11 (100%) | 2/2 (100%) | 27/65 (41.5%) |
* Normal neurological examination except for cranial nerve abnormalities [4].
Therapeutic interventions and outcomes.
| Vitamin A | Vitamin B1 | Vitamin B12 | Presumed | Whole Series | |
|---|---|---|---|---|---|
|
|
|
|
|
|
|
| Oral (n, %) | 12/12 (100%) | 0/40 (0%) | 0/11 (0%) | 2/2 (100%) | 14/65 (21.5%) |
| Parenteral (n, %) | 0/12 (0%) | 39/40 (97.5%) | 11/11 (100%) | 0/2 (0%) | 50/65 (76.9%) |
| Not reported (n, %) | 0/12 (0%) | 1/40 (2.5%) | 0/11 (0%) | 0/2 (0%) | 1/65 (1.5%) |
|
| |||||
| Acetazolamide (n, %) | 2/12 (16.7%) | 0/40(0%) | 1/11 (9.1%) | 2/2 (100%) | 4/65(6.2%) |
|
| |||||
| Full recovery (n, %) | 6/12 (50.0%) | 31/40 (77.5%) | 7/11 (63.6%) | 2/2 (100%) | 46/65 (70.8%) |
| Residual visual defects (n, %) | 6/12 (50.0%) | 4/40 (10.0%) | 4/11 (36.4%) | 0/2 (0%) | 14/65 (21.5%) |
| Residual neurological defects (n, %) | 0/12 (0%) | 5/40 (12.5%) | 0/11 (0%) | 0/2 (0%) | 5/65 (7.7%) |
| Death (n, %) | 0/12 (0%) | 4/40 (10.0%) | 0/11 (0%) | 0/2 (0%) | 5/65 (7.7%) |
| Maternal death (n, %) | - | 2/15 pregnancies (13.3%) | - | - | - |
| Fetal death (n, %) | - | 5/15 pregnancies (33.3%) | - | - | - |